Composite Microbead Protects Cells from Mechanical Stress
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Mammalian cells used in regenerative medicine and biotechnology are susceptible to mechanical stress during processing and delivery, leading to cell death and reduced therapeutic efficacy due to their fragile lipid membrane and lack of structural protection.
Innovation Solution
A composite microbead composed of silk fibroin and a mixture of modified and unmodified alginate, covalently and ionically crosslinked, provides enhanced structural stability and permselectivity, protecting cells from mechanical stress and environmental hazards, and allows on-demand release using a calcium chelator and reducing agent.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If mammalian cells are used for regenerative medicine and biotechnology applications, then cell functionality and therapeutic potential are improved, but cell susceptibility to mechanical stress and environmental hazards increases
Solution Approach 1:
The patent applies this principle by encapsulating mammalian cells within a hydrogel microbead matrix that acts as a flexible protective shell. The hydrogel material provides mechanical protection while maintaining flexibility to accommodate cell functions, shielding cells from shear forces, compressive forces, and other mechanical stresses encountered during processing and delivery.
Solution Approach 2:
The patent implements this principle by creating a composite hydrogel matrix combining multiple materials with complementary properties. The hydrogel system integrates materials that provide mechanical strength, biochemical functionality, and protective characteristics, forming a composite structure that enhances cell protection while maintaining cell viability and function.
2Manufacturing precision
If cells are processed and delivered through injection or 3D bioprinting, then therapeutic delivery precision is improved, but cell exposure to extreme mechanical stress increases
Solution Approach 1:
The patent applies this principle by pre-encapsulating cells in protective hydrogel microbeads before delivery procedures. This beforehand cushioning provides mechanical protection during subsequent processing steps including injection through needles and extrusion through bioprinting nozzles, absorbing and distributing mechanical stresses that would otherwise damage the cells.
Solution Approach 2:
The hydrogel microbead shell provides flexible protection during delivery procedures. The shell's mechanical properties are engineered to withstand compression during injection and extrusion while maintaining cell viability, allowing precise delivery through small gauge needles and bioprinting nozzles without causing extreme mechanical stress to the encapsulated cells.
3Reliability
If composite hydrogel microbeads are used to protect cells, then cell viability during processing is improved, but microbead disintegration by ion exchange increases
Solution Approach 1:
The patent implements this principle by designing a composite hydrogel matrix with carefully selected materials that balance protective functionality with compositional stability. The composite structure incorporates materials resistant to ion exchange disintegration while maintaining the protective functions needed for cell viability during processing and delivery.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composite microbeads significantly enhance cell viability and functional preservation by protecting against mechanical stress, inflammatory cytokines, UV radiation, and harsh culture conditions, improving the success rate of cell delivery and tissue engineering applications.
Implementation Method 1
The composite microbead has reduced disintegration by ion exchange when compared with a comparison microbead
Implementation Method 2
contacting the composite microbead with a mixture of a calcium chelator and a reducing agent
Implementation Method 3
contacting the composite microbead with a mixture of a calcium chelator and a reducing agent
Implementation Method 4
The silk fibroin, the modified alginate, and the unmodified alginate are covalently and ionically crosslinked
Implementation Method 5
The silk fibroin, the modified alginate, and the unmodified alginate are covalently and ionically crosslinked
Data Source
AI summary
A composition is disclosed including a composite microbead that has one or more animal cells embedded therein. The composite microbead has a material matrix composed of silk fibroin and a mixture of modified and unmodified alginate. The composite microbead has reduced disintegration by ion exchange when compared with material lacking the modified alginate. The material matrix is ionically and covalently crosslinked. The animal cells can be on-demand released by contact with a calcium chelator and a reducing agent. The microbeads can be made by introducing droplets of a pre-hydrogel solution including the cells into a crosslinking solution. The resulting microbeads provide the animal cells with an enhanced ability to survive elevated pressures, immunocamouflaging, permselectivity against higher molecular weight molecules, protection from harsh chemical environments, and protection from UV radiation.